Changes and Diagnostic Significance of miR-542-3p Expression in Patients with Myocardial Infarction

Yu Chen,Shuke Liu,Xueshan Zhang,Changpeng Zuo
DOI: https://doi.org/10.1007/s12033-024-01272-w
2024-09-08
Molecular Biotechnology
Abstract:Acute myocardial infarction (AMI) is a heart lesion, that endangers the life safety of patients. This study focused on exploring the clinical effect of miR-542-3p on AMI and no-reflow after percutaneous coronary intervention (PCI). Serum samples were collected from 100 AMI emergency inpatients. The expression of miR-542-3p was quantified by qPCR. The predictive role of miR-542-3p was disclosed by plotting ROC curve. In addition, AMI subjects were cataloged into a group of no-reflow and normal reflow group. The risk factors of no-reflow were estimated by logistic regression analysis. In the serum samples of AMI patients, the level of miR-542-3p showed a pattern of decreasing. MiR-542-3p expression represented a high sensitivity and specificity of the prediction of AMI. A decrease of miR-542-3p content was revealed in AMI patients without reflow after PCI. Logistic regression results reflected that miR-542-3p was an independent biomarker for no-reflow. The declined miR-542-3p expression was a predictive marker for AMI and no-reflow in AMI patients.
biochemistry & molecular biology,biotechnology & applied microbiology
What problem does this paper attempt to address?